In Situ Triggered Self‐Contraction Bioactive Microgel Assembly Accelerates Diabetic Skin Wound Healing by Activating Mechanotransduction and Biochemical Pathway

Abstract Chronic nonhealing skin wounds, characterized by reduced tissue contractility and inhibited wound cell survival under hyperglycemia and hypoxia, present a significant challenge in diabetic care. Here, an advanced self‐contraction bioactive core‐shell microgel assembly with robust tissue‐adhesion (SMART‐EXO) is introduced to expedite diabetic wound healing. The SMART‐EXO dressing exhibits strong, reversible adhesion to damaged tissue due to abundant hydrogen and dynamic coordination bonds. Additionally, the core‐shell microgel components and dynamic coordination bonds provide moderate rigidity, customizable self‐contraction, and an interlinked porous architecture. The triggered in situ self‐contraction of the SMART‐EXO dressing enables active, tunable wound contraction, activating mechanotransduction in the skin and promoting the optimal fibroblast‐to‐myofibroblast conversion, collagen synthesis, and angiogenesis. Concurrently, the triggered contraction of SMART‐EXO facilitates efficient loading and on‐demand release of bioactive exosomes, contributing to re‐epithelialization and wound microenvironment regulation in diabetic mice. RNA‐seq results reveal the activation of critical signaling pathways associated with mechanosensing and exosome regulation, highlighting the combined biomechanical and biochemical mechanisms. These findings underscore SMART‐EXO as a versatile, adaptable solution to the complex challenges of diabetic wound care.